| Literature DB >> 34569275 |
Carlos Augusto Yabar1,2, Giovanny Francesco Vilcarino1, Susan Espetia1, Fiorela Lujan1, Andres Vásquez-Domínguez1, Mariela Yaya1, Maribel Acuña1, Daniel Santos1, Edgardo Mamani1, Rafael Rodriguez-Bayona3, Javier Salvatierra4, George Obregon1, Soledad Romero1, Fany Cardenas1, Pablo Lopez5, Vanessa Rivera-Amill5.
Abstract
HIV-1 genetic diversity and resistance profile might change according to the risky sexual behavior of the host. To show this, we recruited 134 individuals between the years 2015 and 2017 identified as transgender women sex workers (TWSW, n = 73) and Heterosexual Military Officers (HET-MO, n = 61). After obtaining informed consent, we collected a blood sample to perform the HIV genotyping, CD4 cell count, and viral load. We used bioinformatics approaches for detecting resistance mutations and recombination events. Epidemiological data showed that both groups reported sexually transmitted diseases and they were widespread among TWSW, especially syphilis and herpes virus (35.6%). Illegal drugs consumption was higher among TWSW (71.2%), whereas condom use was inconsistent for both HET-MO (57.4%) and TWSW (74.0%). TWSW showed the shortest time exposition to antiretroviral therapy (ART) (3.5 years) and the lowest access to ART (34.2%) that conducted treatment failure (>4 logs). HIV-1 sequences from TWSW and HET-MO were analyzed to determine the genetic diversity and antiretroviral drug resistance. Phylogeny analysis revealed 125 (93%) cases of subtype B, 01 subtype A (0.76%), 07 (5.30%) BF recombinants, and 01 (0.76%) AG recombinant. Also, TWSW showed a higher recombination index (9.5%, 7/73) than HET-MO (1.5%, 1/68). HET-MO only showed acquired resistance (26.23%, 16/61), whereas TWSW showed both acquired as transmitted resistance (9.59% for each). In conclusion, TWSW and HET-MO showed significant differences considering the epidemiological characteristics, genetic diversity, recombination events, and HIV resistance profile.Entities:
Keywords: HIV; antiretroviral therapies; molecular biology; virus evolution/diversity
Mesh:
Year: 2021 PMID: 34569275 PMCID: PMC9206475 DOI: 10.1089/AID.2021.0067
Source DB: PubMed Journal: AIDS Res Hum Retroviruses ISSN: 0889-2229 Impact factor: 1.723